Exact Sciences to Participate in March Investor Conferences

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast.

  • TD Cowen Health Care Conference, Boston

    Fireside chat on Monday, March 3, 2025 at 10:30 a.m. ET
  • Raymond James Institutional Investors Conference, Orlando

    Presentation on Tuesday, March 4, 2025 at 1:05 p.m. ET

The webcasts can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

Contacts

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  204.79
-2.17 (-1.05%)
AAPL  278.69
+5.01 (1.83%)
AMD  211.57
-2.00 (-0.94%)
BAC  53.77
-1.62 (-2.92%)
GOOG  311.44
-7.19 (-2.26%)
META  667.45
-3.27 (-0.49%)
MSFT  405.21
-8.06 (-1.95%)
NVDA  191.59
+3.05 (1.62%)
ORCL  156.52
-3.37 (-2.11%)
TSLA  425.65
+0.44 (0.10%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.